A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women. (25th September 2019)

• Record Type: Journal Article
• Authors: Shieh, Yiwey; Fejerman, Laura; Lott, Paul C; Marker, Katie; Sawyer, Sarah D; Hu, Donglei; Huntsman, Scott; Torres, Javier; Echeverry, Magdalena; Bohórquez, Mabel E; Martínez-Chéquer, Juan Carlos; Polanco-Echeverry, Guadalupe; Estrada-Flórez, Ana P; Haiman, Christopher A; John, Esther M; Kushi, Lawrence H; Torres-Mejía, Gabriela; Vidaurre, Tatianna; Weitzel, Jeffrey N; Zambrano, Sandro Casavilca; Carvajal-Carmona, Luis G; Ziv, Elad; Neuhausen, Susan L
• Is Part Of: Journal of the National Cancer Institute. Volume 112:Number 6(2020)
• Page Start: 590
• Page End: 598
• Publication Date: 2019-09-25
• Subjects: Cancer -- Periodicals; Cancer -- Research -- Periodicals; 616.994
• DOI: 10.1093/jnci/djz174
• Languages: English
• ISSNs: 0027-8874

Abstract

Abstract: Background: More than 180 single nucleotide polymorphisms (SNPs) associated with breast cancer susceptibility have been identified; these SNPs can be combined into polygenic risk scores (PRS) to predict breast cancer risk. Because most SNPs were identified in predominantly European populations, little is known about the performance of PRS in non-Europeans. We tested the performance of a 180-SNP PRS in Latinas, a large ethnic group with variable levels of Indigenous American, European, and African ancestry. Methods: We conducted a pooled case-control analysis of US Latinas and Latin American women (4658 cases and 7622 controls). We constructed a 180-SNP PRS consisting of SNPs associated with breast cancer risk ( P < 5 × 10 –8 ). We evaluated the association between the PRS and breast cancer risk using multivariable logistic regression, and assessed discrimination using an area under the receiver operating characteristic curve. We also assessed PRS performance across quartiles of Indigenous American genetic ancestry. All statistical tests were two-sided. Results: Of 180 SNPs tested, 142 showed directionally consistent associations compared with European populations, and 39 were nominally statistically significant ( P < .05). The PRS was associated with breast cancer risk, with an odds ratio per SD increment of 1.58 (95% confidence interval [CI = 1.52 to 1.64) and an area under the receiver operating characteristic curve of 0.63 (95% CI = 0.62 to 0.64). The discrimination of the PRS was similar between the top and bottom quartiles of Indigenous American ancestry. Conclusions: The 180-SNP PRS predicts breast cancer risk in Latinas, with similar performance as reported for Europeans. The performance of the PRS did not vary substantially according to Indigenous American ancestry.